Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shanghai University of Traditional Chinese Medicine
With
Chongqing Three Gorges Central Hospital
A phase I/II, multicentric,randomized, controlled clinical trial.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed adenocarcinoma of the colon or rectum with non-resectable metastatic disease;
Ages between 18 and 70 years;
Measurable lesion;
Karnofsky Performance Status ≥ 60%;
Estimated life expectancy of at least 6 months;
Participants have no major organ dysfunction and chemotherapy contraindications: hemoglobin ≥90g/L, N \> 1.5×10\^9/L, platelet≥ 100×10\^9/L, normal liver and kidney function;
Informed consent from the patient.
You may not be if
Symptomatic brain metastasis;
Adjuvant or neo-adjuvant treatment for non-metastatic disease in past 6 months;
Serious disease of heart, liver, kidney with severe dysfunction;
Serious complications, such as gastrointestinal tract obstruction and hemorrhage;
Pregnancy or breast-feeding women;
Mental or cognitive disorders;
Be participating other drug trials;
Who are allergic to the study drug.
Clareo Health | Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer
